Ann: Trading Halt, page-74

Investors should reflect on the results in both autism & Retts. These are stunning results providing significant benefits with zero side effects. Although the main game is autism, it's worth noting the Rett's data is superior to Neuren's Daybue without the persistent diarrhoea. All patients have elected to continue. Traders can play their games but this stock offers significant upside and more results will follow in a month. The company had no problem raising $10 million at virtually no discount. That should tell you something.